Exagen Inc (XGN) — Financial Flexibility Index
Exagen Inc (XGN) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of $3.22 Million (operating CF $2.94 Million minus capex $275.00K) represents 0% of total liabilities ($44.69 Million). Also explore Exagen Inc net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Exagen Inc Financial Flexibility Index (2012–2024)
Historical Financial Flexibility Index trend for Exagen Inc across 12 annual periods. Check XGN strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Exagen Inc (2012–2024)
Year-by-year free cash flow to debt coverage for Exagen Inc. For the full company profile including market capitalisation, see XGN stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.36x | $-12.76 Million | $-13.28 Million | $35.15 Million | ▲ +8.8% |
| 2023 | -0.40x | $-13.63 Million | $-14.46 Million | $34.25 Million | ▲ +37.4% |
| 2022 | -0.64x | $-27.83 Million | $-32.14 Million | $43.76 Million | ▼ -36.8% |
| 2021 | -0.46x | $-17.90 Million | $-20.27 Million | $38.51 Million | ▼ -24.6% |
| 2020 | -0.37x | $-13.63 Million | $-14.08 Million | $36.54 Million | ▼ -30.9% |
| 2019 | -0.29x | $-9.31 Million | $-9.71 Million | $32.65 Million | ▼ -11.6% |
| 2018 | -0.26x | $-9.10 Million | $-9.30 Million | $35.62 Million | ▲ +38.5% |
| 2017 | -0.42x | $-10.40 Million | $-10.97 Million | $25.03 Million | ▼ -37.9% |
| 2015 | -0.30x | $-11.10 Million | $-11.90 Million | $36.81 Million | ▲ +7.1% |
| 2014 | -0.32x | $-10.12 Million | $-10.77 Million | $31.20 Million | ▲ +22.4% |
| 2013 | -0.42x | $-6.69 Million | $-6.87 Million | $16.00 Million | ▲ +61.7% |
| 2012 | -1.09x | $-7.04 Million | $-7.48 Million | $6.44 Million | — |